Please assess the completion status of the following clinical trial:

Trial Title: IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Receiving mental health or HIV-related care at participating US IMPAACT site~* Confirmed HIV-1 Infection~* Aware of his or her HIV infection~* Per clinician assessment, primary diagnosis of nonpsychotic depression, including Major Depressive Disorder, Depression Not Otherwise Specified (NOS), or Dysthymia, as defined by Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV or DSM-V criteria~* Current depressive symptoms that warrant intervention as determined by a score of ≥ 11 on the Quick Inventory of Depressive Symptomatology - Clinician (QIDS-C)~* Able to communicate in spoken and written English~* Able and willing to provide written informed assent/consent and able to obtain written parental or guardian permission (if required, as specified in site standard operating procedure (SOP), by State law, and/or Institutional Review Board (IRB) policy) to be screened for and to enroll in IMPAACT 2002~Exclusion Criteria:~* Known or self-reported history of any psychotic disorder and/or bipolar I or II disorder~* Severe disorders (more than 6 symptoms) based on DSM-V criteria related to alcohol, cannabis or other substances; or those with moderate symptoms (4 or 5 symptoms) who are also currently experiencing withdrawal or dependence symptoms; within the past month prior to enrollment~* Per clinician assessment at screening, depression and/or suicidal ideation requiring more intensive treatment than the study provides or at immediate risk of being a danger to themselves or others~* Per participant report at screening, intends to relocate away from the study site during study participation~* Currently in therapy with a non-study provider, unless willing to switch to a study-trained provider~* Has any other condition that, in the opinion of the Investigator of Record (IoR)/designee, would preclude informed assent/consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 24 Years
- Healthy Volunteers: f

Study Arms:
- COMB-R (Type: EXPERIMENTAL): Health and Wellness Cognitive Behavioral Therapy and Medication Management (COMB-R) intervention
- Enhanced Standard of Care (Type: ACTIVE_COMPARATOR): Enhanced Standard of Care (ESC)

Based on this trial design, predict the completion outcome and termination type (if applicable).